|
J Biol Chem, Vol. 273, Issue 33, 21003-21008, August 14, 1998
Preserved Catalytic Activity in an Engineered Ribonucleotide
Reductase R2 Protein with a Nonphysiological Radical Transfer
Pathway
THE IMPORTANCE OF HYDROGEN BOND CONNECTIONS BETWEEN THE
PARTICIPATING RESIDUES*
Monica
Ekberg,
Stephan
Pötsch ,
Elin
Sandin,
Marjolein
Thunnissen,
Pär
Nordlund,
Margareta
Sahlin, and
Britt-Marie
Sjöberg§
From the Departments of Molecular Biology and
Biophysics, University of Stockholm,
S-10691 Stockholm, Sweden
 |
ABSTRACT |
A hydrogen-bonded catalytic radical transfer
pathway in Escherichia coli ribonucleotide reductase (RNR)
is evident from the three-dimensional structures of the R1 and R2
proteins, phylogenetic studies, and site-directed mutagenesis
experiments. Current knowledge of electron transfer processes is
difficult to apply to the very long radical transfer pathway in RNR. To
explore the importance of the hydrogen bonds between the participating
residues, we converted the protein R2 residue Asp237, one
of the conserved residues along the radical transfer route, to an
asparagine and a glutamate residue in two separate mutant proteins. In
this study, we show that the D237E mutant is catalytically active and
has hydrogen bond connections similar to that of the wild type protein.
This is the first reported mutant protein that affects the radical
transfer pathway while catalytic activity is preserved. The D237N
mutant is catalytically inactive, and its tyrosyl radical is unstable,
although the mutant can form a diferric-oxo iron center and a R1-R2
complex. The data strongly support our hypothesis that an absolute
requirement for radical transfer during catalysis in ribonucleotide
reductase is an intact hydrogen-bonded pathway between the radical site
in protein R2 and the substrate binding site in R1. Our data thus
strongly favor the idea that the electron transfer mechanism in RNR is
coupled with proton transfer, i.e. a radical transfer
mechanism.
 |
INTRODUCTION |
The enzyme ribonucleotide reductase
(RNR)1 supplies all living
organisms with the precursors for DNA synthesis by catalyzing the
reduction of ribonucleotides to the corresponding deoxyribonucleotides. Escherichia coli class I RNR is composed of two components,
proteins R1 and R2, both essential for catalytic activity (for a recent review, see Ref. 1). The R1 protein contains the active site, where a
radical-based reaction takes place (2, 3), and a stable tyrosyl radical
involved in the reaction is located at Tyr122 in the R2
protein (4).
The three-dimensional structures of both proteins have been solved to
high resolution (5-8) and used to model a structure of the R1-R2
complex. The model suggests that the active site in R1 and the stable
tyrosyl radical in R2 are connected via an array of conserved residues,
which constitutes the radical transfer pathway. These residues are
Tyr122, Asp84, His118,
Asp237, Trp48, and Tyr356 in the R2
protein and Tyr730, Tyr731, and
Cys439 in the R1 protein (see Fig. 1).
The importance of the radical transfer route has been demonstrated
extensively by site-directed mutagenesis of the E. coli enzyme and also in experiments using selected residues in the mouse
enzyme. Each residue of the radical transfer pathway has been replaced
by another nonphysiological residue, and none of the mutant proteins
could perform ribonucleotide reduction (4, 9-14). In all reported
cases, the side chain of the particular amino acid residue was changed
to a side chain with other hydrogen bonding properties than those of
the original residue in the wild type protein.
The very long (35-40-Å) radical transfer pathway in RNR is hard
to reconcile with current electron transfer theories (15-19), since
the transfer of an electron over such a distance should, according to
theory, take longer time than the actual enzymatic reduction of
substrate. In the current study, our intention was to investigate
further the function of the radical transfer pathway. By altering the
properties of the side chain of one residue, we wanted to assess the
importance of the hydrogen bonds. We converted Asp237 in
the R2 protein into an asparagine and a glutamate residue in two
separate experiments. Asp237 plays an essential role; it
forms hydrogen bonds with His118, Trp48, and
Gln43 and thereby functions as a connecting point for three
helices. It also participates both in the catalytic radical transfer
(12) and in the generation of the tyrosyl radical (20, 51). Our data
emphasize the requirement for hydrogen bonds between the conserved
residues in the radical transfer route and strongly suggest that the
catalytic radical transfer process in RNR is a coupled electron/proton
transfer.
 |
EXPERIMENTAL PROCEDURES |
Materials--
Oligonucleotides used for mutagenesis and
sequencing were synthesized and purified by Scandinavian Gene Synthesis
AB. CzDP was obtained by cleavage of its CTP derivative by incubation
with myosin and subsequent purification on Centricon-10. CzTP was
purchased from Amersham Pharmacia Biotech.
Bacterial Strains--
Escherichia coli CJ236
(dut-1, ung-1, thi-1,
relA/pCJ105 Cmr) and E. coli
MV1190 ( (lac-proAB), thi, supE,
(srl-recA)306::Tn10/F' traD36,
proAB, lacIqZ M15), obtained from
Bio-Rad, were used for mutagenesis and cloning. E. coli
MC1009 ( (lacIPOZYA)X74, galE, galK, strA,
(ara-leu)7697, araD139, recA,
srl::Tn10)/pGP1-2, obtained from Amersham Pharmacia Biotech, was
used for expression.
Plasmids--
pTZ18R, obtained from Amersham Pharmacia Biotech,
contains a T7 promoter upstream of a cloning cassette (22). The plasmid pTB2 is a derivative of pTZ18R, containing the E. coli nrdB
gene, coding for the R2 protein (14). The plasmid pGP1-2, obtained from S. Tabor, codes for T7 polymerase under control of the
PL promoter and a heat-sensitive cI857 repressor under
the control of the Lac promoter (23).
Oligonucleotide-directed Mutagenesis--
Mutagenesis of pTB2
was performed using the Muta-Gene phagemid in vitro
mutagenesis kit from Bio-Rad, based on a method described by Kunkel
(24). Initial verifications of the mutations were done by polymerase
chain reaction of the entire nrdB gene and cleavage with a
restriction enzyme specific for the mutations, MnlI for the
D237E mutation, and BsrDI for the D237N mutation. The entire
gene was then sequenced.
Expression of Mutant R2 Protein--
MC1009/pGP1-2 containing
either pTB2 D237N or pTB2 D237E was grown for several hours at 30 °C
in 10 ml of LB supplemented with kanamycin (50 µg/ml) and
carbenicillin (50 µg/ml). Overnight, 1 liter of the same medium was
inoculated with 0.05 A640 units. The next day, 4 liters of the same medium were inoculated with 200 ml of overnight
culture, divided into four 5-liter flasks, and shaken vigorously (300 rpm) at 30 °C. At A640 = 0.5, the temperature was raised to 42 °C to induce the PL promoter by heat
inactivation of the cI857 repressor. Growth was continued for about
3 h (A640 = 1.3). At harvest, the culture
was quickly chilled and centrifuged at 4000 × g. The
pellets were frozen and stored at 80 °C for further purification.
The D237N mutant protein was overexpressed in the presence of 130 µM bathophenanthrolinesulfonic acid to obtain an apo form
of the protein.
Protein Purification--
Frozen cells were disintegrated in a
BIOX X-press and then resuspended in extraction buffer containing 50 mM Tris, pH 7.6, 20% glycerol, and 10 mM
phenylmethylsulfonyl fluoride. Purification was essentially as
described by Sjöberg et al. (25). The fractions from
the DEAE column that contained R2 were pooled and ultradialyzed in a
buffer containing 50 mM Tris, pH 7.6, and 20% glycerol.
For further purification, the concentrated sample was applied on a fast
protein liquid chromatography MonoQ 10/10 ion exchange column and
eluted with a gradient of NaCl in 50 mM Tris buffer, pH
7.6. The purified protein was then concentrated as described above and
then stored at 80 °C. The purity was monitored by
SDS-polyacrylamide gel electrophoresis. Protein concentrations were
determined using the absorbance at 280 nm minus that at 310 nm. Molar
extinction coefficients of 180,000 M 1
cm 1 for R1 and 120,000 M 1
cm 1 for R2 were used. For crystallization, glycerol was
removed from the MonoQ 10/10 purified protein using a Superdex 200 column and concentrated by Centricon centrifugation.
Iron and Radical Analysis--
The apo D237N mutant protein was
reconstituted with 6 and 3 irons/R2 protein. The reconstitution was
performed at 25 °C by mixing apoprotein in an oxygen-containing
buffer with ferrous iron in an anaerobic solution. The uv-visible
absorbance spectra were collected on a Perkin-Elmer Lambda 2 spectrophotometer. The radical contents of wild type and mutant
proteins were determined from light absorption spectra using an
extinction coefficient of 2,110 M 1
cm 1 for the tyrosyl radical (26). Iron contents were
determined colorimetrically as described previously (27). The radical
stability in the D237N mutant was determined spectrophotometrically by
measuring the 410-nm absorbance at 25 °C every 10th minute for
3 h, with a scan rate of 240 nm/min. Recording of the first
spectrum was started approximately 30 s after the addition of
iron.
R1-R2 Complex Formation--
The R1 interaction with R2 D237E
was determined by measuring the specific activity with a constant R1
concentration of 0.035 µM and concentrations of R2 D237E
varying from 0.04 to 0.70 µM. The R1 interaction with R2
D237N was determined in a series of inhibition experiments where the
mutant R2 was used as an inhibitor of wild type ribonucleotide
reductase activity. The activity was measured with a constant R1
concentration of 0.044 µM, and the R2 concentrations were
varied between 0.05 and 0.8 µM. The concentrations of
inhibitor (R2 D237N) were 0, 0.2, 0.6, and 1.5 µM. The
interaction constants, Kapp, for the different
concentrations of the mutant proteins were determined graphically from
Lineweaver-Burke plots, and Ki for D237N was
determined by plotting Kapp versus inhibitor concentration. Enzyme activity was measured as described below.
Assay of Enzyme Activity--
Assays were performed and analyzed
as described for the [3H]CDP assay (28) in a final volume
of 50 µl with 1.5 mM ATP as effector, 0.5 mM
[3H]CDP (63,000 cpm/nmol) as substrate, and in the
presence of 13 µM thioredoxin and 0.5 µM
thioredoxin reductase. For determination of specific activities, the R1
concentration was 1 µM, and the R2 concentrations were
varied to give at least a 6-fold excess of R1 over R2. One enzyme unit
is defined as the amount of R2 reducing 1 nmol of substrate/min at room
temperature in the presence of excess R1. The specific activity of R2
D237N was determined approximately 2 min after reconstitution of
the protein.
Crystallization and Data Collection--
The D237E mutant was
crystallized in space group P212121
with cell dimensions of 74.4, 85.6, and 115.7 Å. The crystallization of D237E was carried out in Petri dishes by the hanging drop method using the same conditions as for the wild type R2 protein (29). The
reservoir contained 18 or 20% polyethylene glycol 4000 in 50 mM MES buffer, pH 6.0, with 0.2 M sodium
chloride and 1.0 mM ethylmercury thiosalicylate as
additives. The drops contained 5 µl of protein solution at a
concentration of 20 mg/ml and 5 µl of reservoir solution. Diffraction
data were collected to 1.95 Å on a Mar Research image plate mounted on
a Siemens rotating anode. Data were indexed and integrated with Denzo
and scaled and reduced with Scalepack (30). The resulting data comprise 53,000 unique reflections with a redundancy of 3.0, an
Rmerge of 8.5% and a completeness of 96%.
Further data reduction was performed using programs of the CCP4 package
(31) and the software package BIOMOL (Protein Crystallography Group,
University of Groningen, The Netherlands).
Structural Refinement--
The coordinates of reduced wild type
R2 ribonucleotide reductase (32) were used as a starting model for
refinement with TNT (33). The refined model was evaluated and corrected
with Quanta (Molecular Simulations Inc., Burlington, MA). The D237E mutant structure has an R-factor of 18.7% with good
geometry and root mean square differences to the wild type structure of
0.013 Å in bond lengths and of 2.1° in angles.
Kinetic Rate Constants of a Half-turnover Reaction--
The
formation rate of a nitrogen-centered radical at the active site was
determined by monitoring the signal amplitude at two different magnetic
field points in the EPR spectrum. The two fixed points were chosen to
give as high a contribution as possible of the nitrogen-centered
radical and at the same time minimal contribution of the tyrosyl
radical. Measurements were done by stopped flow EPR at room temperature
with final concentrations of 75 µM R1 protein, 50 µM R2 protein, and 1.7 mM CzDP in a buffer containing 50 mM Tris at pH 7.6, 500 µM dTTP,
15 mM MgCl2, 5 mM dithiothreitol.
The binding constant of CzDP to RNR was determined as a function of the
formation of the nitrogen-centered radical at different concentrations
(0.026-1.7 mM) of CzDP.
EPR Measurements--
EPR spectra at 9 GHz were recorded using a
Bruker ESP 300 EPR spectrometer, equipped with a cold finger Dewar for
studies at 77 K. Parameter settings were as follows: modulation
amplitude, 0.16 milliteslas; microwave power, 0.1 milliwatts; time
constant, 327 ms; and sweep time, 83 s. For kinetic studies at
room temperature, a stopped flow accessory type SFA1 (34) was linked
with the ESP 300 Bruker spectrometer. Parameter settings were as
follows: modulation amplitude, 0.5 milliteslas; microwave power, 20 milliwatts; time constant 40-80 ms; and sweep time, 20-40 s. The
kinetic curves were evaluated by using a fitting program, GraFit 3.01, for exponential curves.
 |
RESULTS |
Construction and Overproduction of Mutant R2 Proteins--
The
constructs R2 D237N and D237E contain only the desired GAC to AAT
(D237N) and GAC to GAG (D237E) mutations as verified by dideoxy
sequencing. The D237E mutant R2 behaved like wild type during
overexpression and purification. The D237N mutant had an unstable
radical (see below) and was therefore overexpressed in the presence of
an iron chelator (bathophenanthrolinesulfonic acid) to obtain the apo
form, which could then be reactivated immediately prior to the
experiments. No radical was present in D237N purified from material
produced under normal growth conditions.
Three-dimensional Structure of the Asp Glu Mutant
Protein--
The structure of the D237E mutant showed that a glutamic
acid at position 237 is able to form the same hydrogen bonds as an aspartic acid in the wild type protein (Fig.
1). The lengths of the hydrogen bonds in
the mutant protein differ slightly from those in the wild type protein.
The closest distances between the iron ligand His118 and
Asp237 or Glu237 were similar within
experimental error, 2.7 Å in wild type R2 and 2.6 Å in the mutant R2.
Also connected to Asp237 is Trp48, another
residue in the proposed radical transfer pathway in wild type R2.
Asp237 has only one possibility to form a hydrogen bond to
Trp48, whereas Glu237 in theory can form two
types of hydrogen bond connections to Trp48. The bond
distances were 3.3 and 2.9 Å in the D237E mutant and 2.9 Å in the
wild type protein (Fig. 2, A
and B). However, the shorter bond in the mutant has an angle
that may be unfavorable for a hydrogen bond. Gln43, the
third residue connected to Asp237, is positioned
identically in the D237E mutant and in wild type R2, with a hydrogen
bond distance of 3.3 Å in the mutant and 3.0 Å in the wild type.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Radical transfer pathway model built from
three-dimensional structures of protein R1 and wild type R2 or R2
D237E. Wild type protein (light gray) is
compared with the side chain of the mutant D237E protein
(dark gray), and hydrogen bond connections are
indicated as dashed lines. This figure
was generated with Bobscript, a modified version of Molscript (21,
50).
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
Hydrogen bond distances from the mutated
residue (Asp237) to the neighboring residues in the radical
transfer pathway (Trp48 and His118) from the
three-dimensional structures of wild type protein (32)
(A), and D237E mutant protein (B). This
figure was generated using Quanta (Molecular Simulations
Inc.) and Photoshop (Adobe Systems Inc.).
|
|
Iron Binding, Tyrosyl Radical Formation, and Interaction with the
R1 Protein of the Asp Glu and Asp Asn Mutant R2
Proteins--
Light absorption spectra for wild type and mutant R2
proteins are shown in Fig. 1. Active wild type R2 shows a sharp peak at
410 nm, related to the tyrosyl radical, and absorbances at 325 and 370 nm related to the diiron-oxo center (Fig.
3A). Both mutant proteins
could form a tyrosyl radical and also an oxo-bridged iron center (Fig.
3, B and C), although the spectrum of the D237N mutant protein was not as well resolved as were the wild type and the
D237E spectra.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 3.
Light absorption spectra of wild type and
mutant R2 proteins. Actual protein concentrations of 9-12
µM were normalized to 10 µM. A,
wild type protein. B, D237N mutant protein, apo spectrum
(lower trace); spectrum recorded (scan rate 240 nm/min) approximately 30 s after reconstitution with 6 irons
(upper trace) and 3 irons (middle
trace) per R2 dimer. C, D237E mutant
protein.
|
|
The iron and radical contents of wild type and mutant R2 proteins are
presented in Table I. The data of wild
type R2 and D237E are almost identical, whereas the iron content was
higher, and the amount of radical formed was slightly lower in the
D237N than in the wild type protein. However, these differences are small and not likely to be a major cause of loss of enzyme activity (see below).
The radical of the D237E mutant protein was as stable as the radical of
the wild type protein. In contrast, the radical of the D237N mutant
decayed with a rate constant of 0.37/h at 25 °C, which corresponds
to a half-life of about 110 min (Table I).
We determined the R1-R2 interaction constants for the mutant R2
proteins. Table I shows that both mutant proteins have interaction constants similar to that of the wild type. From these data, we concluded that the mutant R2 proteins are not affected in their ability
to bind to wild type R1.
The Asp Glu Mutant Is Catalytically Active, in Contrast to the
Asp Asn Mutant--
The specific activities of both mutant
proteins were measured and are presented in Table
II. The D237E was shown to have a significant enzyme activity, about 7% of the wild type activity. This
is the first observation of a mutant affecting the radical transfer
route in RNR that can still catalyze ribonucleotide reductase reduction. The low activity measured in the D237N mutant protein (0.3%
of the wild type activity) corresponds approximately to the estimated
amount of chromosomally encoded wild type protein in preparations from
MC1009/pTB2/pGP1-2 constructs. It is therefore plausible that the
D237N mutant protein per se is incapable of ribonucleotide
reduction and that the low activity observed is due to a very small
fraction of wild type contamination.
View this table:
[in this window]
[in a new window]
|
Table II
Specific activity and rate constants for formation of the
nitrogen-centered radical (CzDP*) in wild type and mutant R2 protein
The rate constants were measured by stopped flow EPR at room
temperature.
|
|
To differentiate between a low intrinsic enzyme activity in the mutant
proteins and a low amount of contaminating wild type activity, we used
the substrate analogue CzDP. CzDP is a suicidal substrate analogue that
scavenges the tyrosyl radical of R2 in a single half-turnover reaction
catalyzed by the holoenzyme (35-37). A protein with an intact radical
transfer route will form a nitrogen-centered radical at the active site
in R1 at the expense of the tyrosyl radical in R2, whereas a protein
with a disrupted radical transfer route will not form the
nitrogen-centered radical, and the tyrosyl radical will consequently
not be lost. By CzDP inactivation experiments, we showed that the D237N
mutant protein was unable to perform radical transfer. No
nitrogen-centered radical was formed, and the tyrosyl radical decay had
the same rate constant as in the isolated D237N protein. In the D237E
mutant protein, the radical transfer was functional; we could observe a
nitrogen-centered radical and a tyrosyl radical decay.
The CzDP-dependent Reaction Is Slowed Down in the Asp
Glu Mutant Protein--
To determine an accurate formation rate
for the nitrogen-centered radical in the D237E mutant protein and wild
type R2 protein, we used stopped flow EPR spectroscopy at room
temperature (Table II). The formation rate of the nitrogen-centered
radical in the D237E protein was 0.084 s 1, which is
approximately 8 times slower than in the wild type. The corresponding
tyrosyl radical decay was 0.044 s 1, indicating that this
mutant enzyme can perform radical transfer. The overall rate of the
half turnover reaction in the mutant D237E is approximately 10% of the
corresponding wild type rate (Table II). The only difference between
the wild type and the mutant systems is the mutation in the R2 protein,
since the same R1 wild type protein was used in both reactions.
CzDP Has the Same Binding Constant as CDP--
The rate constant
for formation of the nitrogen-centered radical in wild type protein was
determined to be 0.7 s 1 (Table II), which is faster than
previously reported values of 0.23 min 1 (36, 38),
probably due to the efficient mixing technique used here. The decay
rate of this radical (data not shown) agrees with the earlier published
value (36). In comparison with kcat of the
enzyme, which is about 7 s 1, the
CzDP-dependent reaction is a 10 times slower process. To exclude the possibility that the slower reaction rate with the CzDP
substrate analogue was due to a nonsaturating CzDP concentration or a
defective binding of the analogue to the active site, we determined the
binding constant of CzDP to the wild type holoenzyme complex. The
Lineweaver-Burke plot of Fig. 4 shows
that the binding constant for CzDP is 0.27 mM. Using the
method of Ormö et al. (39), we obtained a similar
binding constant for the normal substrate CDP, a value that is in
accordance with the previously reported CDP binding constant of 0.25 mM obtained by equilibrium dialysis (40). From this, we
concluded that the slower rate of the suicidal reaction with CzDP in
wild type protein as compared with the multiple turnover of the CDP
substrate is not due to decreased or defective binding of the analogue.
Instead, it is most likely due to differences in the chemical reaction
mechanism.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 4.
Determination of the binding constant for the
substrate analogue CzDP to wild type R1-R2 complex. The observed
rate constants for formation of the nitrogen-centered radical at
increasing concentrations of CzDP were determined by stopped flow EPR
spectroscopy at room temperature.
|
|
 |
DISCUSSION |
The existence of a dedicated radical transfer route in E. coli RNR has been established by a combination of
three-dimensional structure determinations, phylogenetic sequence
comparisons, and site-directed mutagenesis experiments. As long ago as
1990 when the three-dimensional structure of the R2 protein was solved, Nordlund et al. (5) pointed out that an array of three
strictly conserved residues connected the diiron site in R2 with the
surface of the protein through hydrogen bonds. The subsequently solved three-dimensional structure of protein R1 showed that there was a short
array of three hydrogen-bonded conserved residues connecting the active
site of R1 with the surface of the protein (7). The modeling of an
R1-R2 complex brought the two arrays of hydrogen-bonded residues
together. A complete radical transfer route between the tyrosyl radical
in R2 and the active site in R1 plausibly also comprises the R2 residue
Tyr356 (Fig. 1), which has been shown to be essential for
binding of R2 to R1 (11) but which belongs to a disordered C-terminal
part of the three-dimensional structure of the isolated R2 (5).
Extensive site-directed mutagenesis data support our hypothesis that
this radical transfer pathway involves at least nine conserved
residues, six in R2 and three in R1 (cf. Fig. 1).
Substitutions in four of these conserved residues in E. coli
R2 (4, 11, 14) and all three in R1 (9, 10, 13) led to catalytically inactive enzymes. In related experiments in mouse R2, the two remaining
conserved residues were substituted and shown to be part of the
corresponding radical transfer pathway in this enzyme (12). However,
all mutant proteins that have been constructed to date to affect the
radical transfer pathway have been catalytically inert, since the
active groups of the amino acid side chains have been removed by the
engineering.
In this study, we have used site-directed mutagenesis to explore
further the mechanism of catalytic radical transfer. We constructed two
mutants, D237E and D237N, into one of the residues along the radical
transfer pathway and showed that it can function with a mutant residue,
provided that the hydrogen bonds and their character are preserved, as
is the case in D237E. The glutamic acid in position 237 can form the
same hydrogen bonds to Trp48 and His118 as in
the wild type. The slightly longer distance of the bond to
Trp48 (2.9 Å in wild type R2 and 3.3 Å in D237E) in the
mutant suggests a weaker hydrogen bond, which could explain the reduced
enzymatic activity of the D237E mutant.
The D237N mutant was inactive, although an asparagine residue is
similar in size to aspartate and theoretically has the ability to form
hydrogen bonds with other residues. To date, we have not been able to
crystallize the D237N mutant. However, the preserved iron content,
initial radical content, and R1-R2 interaction of the D237N mutant as
compared with wild type R2 suggest that the loss of activity and the
destabilization of the tyrosyl radical are due to a local structural
change around the mutation. In yeast cytochrome c peroxidase
(CCP), where a homologous His-Asp-Trp electron transfer pathway exists,
it has been shown that the corresponding Asp Asn mutant protein
lacks the hydrogen bond to Trp because the indole side chain has
flipped as a result of the mutation (41, 42).
A similar engineering experiment has also been performed in mouse
protein R2, where it was shown that an Asp Ala mutation at position
266 (corresponding to Asp237 in the E. coli
enzyme) is catalytically inert (12). In contrast to the mouse D266A R2,
which is a stable mutant, an alanine in the 237 position of E. coli R2 destabilizes the protein, which is extensively degraded
during the purification procedure (43).
It has previously been shown that the hydrogen bonds between
Cys439, Tyr730, and Tyr731 in
protein R1 are essential for radical transfer in RNR (13). Engineering
of either of the two tyrosines into phenylalanines in separate
experiments led to catalytically inert mutants. The conclusion was that
the preserved -interaction between the aromatic rings in these
mutant R1 proteins is not enough for radical transfer to occur (13),
again emphasizing that an intact hydrogen-bonded network is
important.
The radical transfer pathway in RNR is very long, about 35-40 Å, and
therefore difficult to reconcile with current electron transfer
theories (15-17, 19), which predict electron transfer rates that are
orders of magnitude slower ( 0.005 s 1; Ref. 19) than
the actual catalytic rate of the enzyme (1). Even the fact that
hydrogen-bonded connections are more efficient than covalent bonds in
electron transfer (18) is not sufficient to account for the catalytic
rate of RNR. Recently a quantum chemical model study of hydrogen
transfer between amino acids in the presence of radicals has been
presented (44). These data suggest that many processes normally
considered as electron transfer reactions in biological systems could
be better explained as radical transfer processes, i.e. an
electron concomitantly transferred with a proton. A radical transfer
process would preserve neutrality and is energetically more favorable
than a charge separation mechanism. Since charge separation is not
required during RNR catalysis, radical transfer seems to be the most
efficient and rational way to communicate the electron and fits very
well with our experimental data on catalysis in RNR. A coupled
electron/proton transfer process has also been suggested to occur in
both E. coli and mouse protein R2 during the reconstitution
reaction, where one of the four electrons needed to reduce molecular
oxygen to water is suggested to use the Trp-Asp-His triad (20, 51).
CCP and its specific redox partner, cytochrome c, have been
studied as a model system for intermolecular electron transfer process
in proteins (45-49). There are striking similarities between the
radical transfer routes in CCP and RNR. In both proteins, a
hydrogen-bonded triad, consisting of
His175-Asp235-Trp191 in CCP and
His118-Asp237-Trp48 in R2 RNR, has
its histidine residue coordinated to the metal site and its tryptophan
residue at the protein surface. Asp235 in CCP
(corresponding to Asp237 in RNR) has been converted into
asparagine, alanine, and glutamate by site-directed mutagenesis
experiments (42). Both D235N and D235A were unable to catalyze
cytochrome c oxidation (<0.1% of the wild type CCP
activity), but D235E showed 41% wild type activity. Structural data
showed that the asparagine and alanine mutants completely destroyed the
hydrogen bonding interaction in CCP, whereas the substitution to
glutamate introduced only subtle changes in the hydrogen bonding
interaction with Trp191 and His175 (41,
42).
The data presented in this study show that the radical transfer route
in ribonucleotide reductase is not amino acid-specific but that the
ability to form similar hydrogen bonds to the surrounding residues
needs to be conserved in a functional enzyme. Also, the efficiency of
radical transfer seems to depend strongly on the nature of the hydrogen
bonds. The importance of the hydrogen bonds implies that the catalytic
radical transfer process in RNR is a coupled electron/proton transfer
process.
 |
ACKNOWLEDGEMENT |
We thank Agneta Slaby for help with
determination of the CDP binding constant.
 |
FOOTNOTES |
*
This work was supported by grants from the Swedish Cancer
Society to (B.-M. S.), Deutscher Akademischer Austauschdienst (to S. P.), and the Magn. Bergvall Foundation (M. S.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Molecular
Biology, Stockholm University. Tel.: 46-8-164150; Fax: 46-8-152350; E-mail: Britt-Marie.Sjoberg{at}molbio.su.se.
The abbreviations used are:
RNR, ribonucleotide
reductase; CCP, cytochrome c peroxidaseCzDP, 2'-azido-2'-deoxy-CDPCzTP 2'-azido-2'-deoxy-CTP, MES,
4-morpholineethanesulfonic acid.
 |
REFERENCES |
-
Sjöberg, B.-M.
(1997)
Struct. Bonding
88,
139-173
-
Stubbe, J. A.,
and van der Donk, W. A.
(1995)
Chem. Biol.
2,
793-801[CrossRef][Medline]
[Order article via Infotrieve]
-
Persson, A. L.,
Eriksson, M.,
Katterle, B.,
Pötsch, S.,
Sahlin, M.,
and Sjöberg, B.-M.
(1997)
J. Biol. Chem.
272,
31533-31541[Abstract/Free Full Text]
-
Larsson, A.,
and Sjöberg, B.-M.
(1986)
EMBO J.
5,
2037-2040[Medline]
[Order article via Infotrieve]
-
Nordlund, P.,
Sjöberg, B.-M.,
and Eklund, H.
(1990)
Nature
345,
593-598[CrossRef][Medline]
[Order article via Infotrieve]
-
Nordlund, P.,
and Eklund, H.
(1993)
J. Mol. Biol.
232,
123-164[CrossRef][Medline]
[Order article via Infotrieve]
-
Uhlin, U.,
and Eklund, H.
(1994)
Nature
370,
533-539[CrossRef][Medline]
[Order article via Infotrieve]
-
Eriksson, M.,
Uhlin, U.,
Ramaswamy, S.,
Ekberg, M.,
Regnström, K.,
Sjöberg, B.-M.,
and Eklund, H.
(1997)
Structure
5,
1077-1092[Medline]
[Order article via Infotrieve]
-
Åberg, A.,
Hahne, S.,
Karlsson, M.,
Larsson, A.,
Ormö, M.,
Åhgren, A.,
and Sjöberg, B.-M.
(1989)
J. Biol. Chem.
264,
12249-12252[Abstract/Free Full Text]
-
Mao, S. S.,
Holler, T. P.,
Yu, G. X.,
Bollinger, J. M.,
Booker, S.,
Johnston, M. I.,
and Stubbe, J.
(1992)
Biochemistry
31,
9733-9743[CrossRef][Medline]
[Order article via Infotrieve]
-
Climent, I.,
Sjöberg, B.-M.,
and Huang, C. Y.
(1992)
Biochemistry
31,
4801-4807[CrossRef][Medline]
[Order article via Infotrieve]
-
Rova, U.,
Goodtzova, K.,
Ingemarson, R.,
Behravan, G.,
Gräslund, A.,
and Thelander, L.
(1995)
Biochemistry
34,
4267-4275[CrossRef][Medline]
[Order article via Infotrieve]
-
Ekberg, M.,
Sahlin, M.,
Eriksson, M.,
and Sjöberg, B.-M.
(1996)
J. Biol. Chem.
271,
20655-20659[Abstract/Free Full Text]
-
Persson, B. O.,
Karlsson, M.,
Climent, I.,
Ling, J. S.,
Sanders Loehr, J.,
Sahlin, M.,
and Sjöberg, B.-M.
(1996)
J. Biol. Inorg. Chem.
1,
247-256[CrossRef]
-
Marcus, R. A.,
and Sutin, N.
(1985)
Biochim. Biophys. Acta
811,
265-322
-
Beratan, D. N.,
Betts, J. N.,
and Onuchic, J. N.
(1991)
Science
252,
1285-1288[Abstract/Free Full Text]
-
Moser, C. C.,
Keske, J. M.,
Warncke, K.,
Farid, R. S.,
and Dutton, P. L.
(1992)
Nature
355,
796-802[CrossRef][Medline]
[Order article via Infotrieve]
-
de Rege, P. J.,
Williams, S. A.,
and Therien, M. J.
(1995)
Science
269,
1409-1413[Abstract/Free Full Text]
-
Gray, H. B.,
and Winkler, J. R.
(1996)
Annu. Rev. Biochem.
65,
537-561[CrossRef][Medline]
[Order article via Infotrieve]
-
Katterle, B.,
Sahlin, M.,
Schmidt, P. P.,
Pötsch, S.,
Logan, D. T.,
Gräslund, A.,
and Sjöberg, B.-M.
(1997)
J. Biol. Chem.
272,
10414-10421[Abstract/Free Full Text]
-
Kraulis, P. J.
(1991)
J. Appl. Crystallogr.
24,
946-950[CrossRef]
-
Mead, D. A.,
Szczesna-Skorupa, E.,
and Kemper, B.
(1986)
Protein Eng.
1,
67-74[Abstract/Free Full Text]
-
Tabor, S.,
and Richardson, C. C.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
1074-1078[Abstract/Free Full Text]
-
Kunkel, T. A.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
488-492[Abstract/Free Full Text]
-
Sjöberg, B.-M.,
Hahne, S.,
Karlsson, M.,
Jörnvall, H.,
Göransson, M.,
and Uhlin, B. E.
(1986)
J. Biol. Chem.
261,
5658-5662[Abstract/Free Full Text]
-
Bollinger, J. M.,
Tong, W. H.,
Ravi, N.,
Huynh, B. H.,
Edmondson, D. E.,
and Stubbe, J.
(1994)
J. Am. Chem. Soc.
116,
8015-8023[CrossRef]
-
Sahlin, M.,
Sjöberg, B.-M.,
Backes, G.,
Loehr, T.,
and Sanders-Loehr, J.
(1990)
Biochem. Biophys. Res. Commun.
167,
813-818[CrossRef][Medline]
[Order article via Infotrieve]
-
Thelander, L.,
Sjöberg, B.-M.,
and Eriksson, S.
(1978)
Methods Enzymol.
51,
227-237[Medline]
[Order article via Infotrieve]
-
Nordlund, P.,
Uhlin, U.,
Westergren, C.,
Joelsen, T.,
Sjöberg, B.-M.,
and Eklund, H.
(1989)
FEBS Lett.
258,
251-254[CrossRef][Medline]
[Order article via Infotrieve]
-
Otwinowsky, Z.
(1993)
Proceedings of the CCP4 Study Weekend, pp. 56-62, SERC Daresbury Laboratory, Warrington, UK
-
Collaborative Computational Project No. 4.
(1994)
Acta Crystallogr. Sec. D
50,
760-763[CrossRef][Medline]
[Order article via Infotrieve]
-
Logan, D. T.,
Su, X. D.,
Åberg, A.,
Regnström, K.,
Hajdu, J.,
Eklund, H.,
and Nordlund, P.
(1996)
Structure
4,
1053-1064[Medline]
[Order article via Infotrieve]
-
Tronrud, D. E.,
Ten Eyck, L. F.,
and Matthews, B. W.
(1987)
Acta Crystallogr. Sec. A
43,
489-501[CrossRef]
-
Lassmann, G.,
Thelander, L.,
and Gräslund, A.
(1992)
Biochem. Biophys. Res. Commun.
188,
879-887[CrossRef][Medline]
[Order article via Infotrieve]
-
Thelander, L.,
and Larsson, B.
(1976)
J. Biol. Chem.
251,
1398-1405[Abstract/Free Full Text]
-
Sjöberg, B.-M.,
Gräslund, A.,
and Eckstein, F.
(1983)
J. Biol. Chem.
258,
8060-8067[Abstract/Free Full Text]
-
van der Donk, W. A.,
Stubbe, J.,
Gerfen, G. J.,
Bellew, B. F.,
and Griffin, R. G.
(1995)
J. Am. Chem. Soc.
117,
8908-8916[CrossRef]
-
Salowe, S.,
Bollinger, J. M.,
Ator, M.,
Stubbe, J.,
Mccracken, J.,
Peisach, J.,
Samano, M. C.,
and Robins, M. J.
(1993)
Biochemistry
32,
12749-12760[CrossRef][Medline]
[Order article via Infotrieve]
-
Ormö, M.,
and Sjöberg, B.-M.
(1990)
Anal. Biochem.
189,
138-141[CrossRef][Medline]
[Order article via Infotrieve]
-
von Döbeln, U.,
and Reichard, P.
(1976)
J. Biol. Chem.
251,
3616-3622[Abstract/Free Full Text]
-
Wang, J. M.,
Mauro, M.,
Edwards, S. L.,
Oatley, S. J.,
Fishel, L. A.,
Ashford, V. A.,
Xuong, N. H.,
and Kraut, J.
(1990)
Biochemistry
29,
7160-7173[CrossRef][Medline]
[Order article via Infotrieve]
-
Goodin, D. B.,
and McRee, D. E.
(1993)
Biochemistry
32,
3313-3324[CrossRef][Medline]
[Order article via Infotrieve]
-
Persson, B. O. (1997) The iron centre of ribonucleotide
reductase protein R2 of Escherichia coli. Effects of protein
engineering of the iron ligands. ISBN 91-7153-628-0, Ph. D. thesis, Stockholm University, Sweden
-
Siegbahn, P. E. M.,
Blomberg, M. R. A.,
and Crabtree, R. H.
(1997)
Theor. Chem. Acc.
97,
289-300[CrossRef]
-
Poulos, T. L.,
and Kraut, J.
(1980)
J. Biol. Chem.
255,
10322-10330[Abstract/Free Full Text]
-
Poulos, T. L.,
and Kraut, J.
(1980)
J. Biol. Chem.
255,
8199-8205[Free Full Text]
-
Waldmeyer, B.,
Bechtold, R.,
Bosshard, H. R.,
and Poulos, T. L.
(1982)
J. Biol. Chem.
257,
6073-6076[Abstract/Free Full Text]
-
Ho, P. S.,
Sutoris, C.,
Liang, N.,
Margoliash, E.,
and Hoffman, B. M.
(1985)
J. Am. Chem. Soc.
107,
1070-1071[CrossRef]
-
Hazzard, J. T.,
Poulos, T. L.,
and Tollin, G.
(1987)
Biochemistry
26,
2836-2848[CrossRef][Medline]
[Order article via Infotrieve]
-
Esnouf, R. M.
(1997)
J. Mol. Graphics
15,
133-138
-
Schmidt, P. P., Rova, U., Katterle, B., Thelander, L., and
Gräslund, A. (1998) J. Biol. Chem. 273, in
press
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Narvaez, N. Voevodskaya, L. Thelander, and A. Graslund
The Involvement of Arg265 of Mouse Ribonucleotide Reductase R2 Protein in Proton Transfer and Catalysis
J. Biol. Chem.,
September 8, 2006;
281(36):
26022 - 26028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kasrayan, P. L. Birgander, L. Pappalardo, K. Regnstrom, M. Westman, A. Slaby, E. Gordon, and B.-M. Sjoberg
Enhancement by Effectors and Substrate Nucleotides of R1-R2 Interactions in Escherichia coli Class Ia Ribonucleotide Reductase
J. Biol. Chem.,
July 23, 2004;
279(30):
31050 - 31057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ekberg, P. Birgander, and B.-M. Sjoberg
In Vivo Assay for Low-Activity Mutant Forms of Escherichia coli Ribonucleotide Reductase
J. Bacteriol.,
February 15, 2003;
185(4):
1167 - 1173.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Strand, S. Karlsen, and K. K. Andersson
Cobalt Substitution of Mouse R2 Ribonucleotide Reductase as a Model for the Reactive Diferrous State. SPECTROSCOPIC AND STRUCTURAL EVIDENCE FOR A FERROMAGNETICALLY COUPLED DINUCLEAR COBALT CLUSTER
J. Biol. Chem.,
September 6, 2002;
277(37):
34229 - 34238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kasrayan, A. L. Persson, M. Sahlin, and B.-M. Sjoberg
The Conserved Active Site Asparagine in Class I Ribonucleotide Reductase Is Essential for Catalysis
J. Biol. Chem.,
February 15, 2002;
277(8):
5749 - 5755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Krupenko and C. Wagner
Aspartate 142 Is Involved in Both Hydrolase and Dehydrogenase Catalytic Centers of 10-Formyltetrahydrofolate Dehydrogenase
J. Biol. Chem.,
December 10, 1999;
274(50):
35777 - 35784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sun and J. Conner
The U28 ORF of human herpesvirus-7 does not encode a functional ribonucleotide reductase R1 subunit
J. Gen. Virol.,
October 1, 1999;
80(10):
2713 | |